SCHEMBL29981797

SCHEMBL29981797

COc1cc(-c2nccc(-c3cccc(-c4ccc(CNC5CCOCC5)c(OC)n4)c3Cl)c2Cl)cnc1CNC1CCOCC1

nearest known ligand 0.57

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ CD274 Q9NZQ7 20/20 0.57
▸ PDCD1 Q15116 8/20 0.57
▸ PDCD1LG2 Q9BQ51 12/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27079250 1.00 CD274 (0.57) CD274PDCD1PDCD1LG2
SCHEMBL27079458 0.91 CD274 (0.60) CD274PDCD1PDCD1LG2
SCHEMBL27080493 0.89 CD274 (0.52) CD274PDCD1PDCD1LG2
SCHEMBL29982268 0.89 CD274 (0.52) CD274PDCD1PDCD1LG2
SCHEMBL29983446 0.88 PDCD1 (0.52) CD274PDCD1
SCHEMBL27078983 0.88 PDCD1 (0.52) CD274PDCD1
SCHEMBL27079663 0.87 CD274 (0.62) CD274PDCD1PDCD1LG2
SCHEMBL29982690 0.87 CD274 (0.71) CD274PDCD1PDCD1LG2
SCHEMBL27079547 0.87 CD274 (0.71) CD274PDCD1PDCD1LG2
SCHEMBL29982215 0.87 CD274 (0.61) CD274PDCD1PDCD1LG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4313968-A2 SUBSTITUTED 1-ARYL-1'-HETEROARYL COMPOUNDS, SUBSTITUTED 1,1'-BIHETEROARYL COMPOUNDS, AND METHODS USING SAME Arbutus Biopharma Corporation (CA) 2024-02-07 — — EP claimed
WO-2022208269-A2 SUBSTITUTED 1-ARYL-1'-HETEROARYL COMPOUNDS, SUBSTITUTED 1,1'-BIHETEROARYL COMPOUNDS, AND METHODS USING SAME ARBUTUS BIOPHARMA CORPORATION (CA) 2022-10-06 — — WO claimed
EP-4313968-A2 SUBSTITUTED 1-ARYL-1'-HETEROARYL COMPOUNDS, SUBSTITUTED 1,1'-BIHETEROARYL COMPOUNDS, AND METHODS USING SAME Arbutus Biopharma Corporation (CA) 2024-02-07 — — EP disclosed
WO-2022208269-A2 SUBSTITUTED 1-ARYL-1'-HETEROARYL COMPOUNDS, SUBSTITUTED 1,1'-BIHETEROARYL COMPOUNDS, AND METHODS USING SAME ARBUTUS BIOPHARMA CORPORATION (CA) 2022-10-06 — — WO disclosed
Send feedback